In navigating the multifaceted landscape of marijuana policy reform, the FDA’s exhaustive examination of cannabis, supplemented by insights from social media analysis, illuminates the intricate dynamics at play. Despite the agency’s recommendation for rescheduling, political pressures from congressional figures and stakeholders present hurdles towards a definitive decision.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…